Cams Mosl

Download as pdf or txt
Download as pdf or txt
You are on page 1of 10

7 November 2022

2QFY23 Results Update | Sector: Financials

CAMS
Estimate change CMP: INR2,449 TP: INR2,900 (+18%) Buy
TP change
Rating change
Strong outlook for non-MF businesses
 CAMS reported a PAT of INR721m in 2QFY23, +12% QoQ but 4.7% below our
Bloomberg CAMS IN estimates. A 2% miss on revenue along with a higher-than-expected tax rate
Equity Shares (m) 49 resulted in a weaker-than-estimated PAT. EBITDA margin was at 43.8% (below
M.Cap.(INRb)/(USDb) 120 / 1.5
our estimate of 45.1%) v/s 41.4%/46.5% in 1QFY23/2QFY22, respectively.
52-Week Range (INR) 3250 / 2039
1, 6, 12 Rel. Per (%) -6/-9/-21  Management entered into revised agreements with all but one of its major
12M Avg Val (INR M) 601 AMC customers wherein some have rolled over agreements on existing
pricing, while a few have taken some cuts. Non-MF businesses particularly
Financials & Valuations (INR b) AIF, Insurance Repository and Account Aggregator are expected to grow at
Y/E March 2023E 2024E 2025E a healthy pace from FY24.
AAUM (INR t) 28.3 32.3 37.0
 We adjust our earnings to factor in the earnings miss in 2QFY23 and
Revenue 9.9 11.4 13.0
EBITDA 4.4 5.1 6.0 increased confidence of management on non-MF businesses’ growth
Margin (%) 43.9 45.1 46.3 outlook. Resultantly, we cut our EPS estimates for FY23/FY24/FY25 by
PAT 2.9 3.6 4.3 5%/4%/2%, respectively. Maintain BUY with a one-year TP of INR2,900
PAT Margin (%) 30 31 33
(premised on 36x Sep’24 EPS).
EPS 60.0 72.6 87.2
EPS Grw. (%) 2.2 21.0 20.1 Margins recover from the 1QFY23 lows
BVPS 153.4 178.8 209.4
 QAAUM stood at INR27t (+3% QoQ). Equity AuM rose 11% in Sep’22 over
RoE (%) 42.0 43.7 44.9
Div. Payout (%) 65.0 65.0 65.0 Jun’22. Operating revenue grew 6% YoY/2% QoQ to INR2.42b. This was
Valuations broadly in line with our estimates.
P/E (x) 40.9 33.8 28.1  Share of Non-MF businesses in revenue was at 9.8% in 2QFY23 vs 9.6% in
P/BV (x) 16.0 13.7 11.7
Div. Yield (%) 1.6 1.9 2.3
1QFY23. Alternative Services vertical continued with its high-growth
trajectory, recording ~32% YoY growth in revenue in 2QFY23. eInsurance
Shareholding pattern (%) Account and e-Policy doubled in volume over 1QFY23, aided by sustained
As On Sep-22 Jun-22 Sep-21 news of KYC requirements, eIA and e-Policy.
Promoter 19.9 23.7 31.0  EBITDA came in at INR1,061m (5% below our estimate) and EBITDA margin
DII 14.9 14.7 15.2 stood at 43.8% v/s 46.5%/41.4% in 2QFY22/1QFY23, respectively. PAT grew
FII 33.2 29.3 26.5 12% QoQ to INR721m during the quarter.
Others 32.0 32.3 27.4  Sales/EBITDA/PAT for 1HFY23 grew 12%/3%/1% to INR4,780m/INR2,040m/
FII Includes depository receipts INR1,368m, respectively. The Board declared an interim dividend of INR8.5/sh.
Key takeaways from the management commentary
 Barring one, CAMS has entered into new agreements with all major AMCs
and does not expect revisions in the next 2-3 years. Some contracts have
been rolled over at previous rates while a few have seen marginal reduction
in pricing.
 AIF segment clocked 32% YoY growth in 2QFY23 with more than one signings
every week. CAMS has gained significant market share in this segment.
Tweak estimates to factor in PAT miss and strong non-MF revenue outlook
 Empirically, CAMS has traded at a premium to listed AMCs in terms of one-
year forward P/E. This premium is well deserved, given: 1) the duopoly
nature of the industry and high-entry barriers, 2) relatively low risk of a
market share loss, and 3) higher customer ownership as compared to AMCs.

Prayesh Jain - Research Analyst ([email protected])


Nitin Aggarwal - Research Analyst ([email protected])
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.
CAMS

 Based on one-year forward P/E multiple, the premium enjoyed by CAMS over
HDFC AMC has narrowed to 20% from 60% over the last one year. This was on
account of the weak environment in the AMC space, given the pressure on
yields, outflows from the Debt segment, and an MTM hit on Equity AUM. We
expect these factors to reverse in the coming months, as the intensity of the fall
in yields abates, debt inflows increase with the topping of bond yields and a
rebound in the equity market.
 We adjust our earnings to factor in the earnings miss in 2QFY23 and increased
confidence of management on non-MF businesses’ growth outlook. Resultantly,
we cut our EPS estimates for FY23/FY24/FY25 by 5%/4%/2%, respectively. CAMS
is expected to deliver a revenue/EBITDA/PAT CAGR of 13%/12%/14% over FY22-
25, respectively, with an RoE of 44.9% in FY25. We maintain our BUY rating
with a one-year TP of INR2,900 (premised on 36x Sep’24 EPS).

Quarterly Performance (INR m)


Y/E March FY22 FY23 Act v/s
FY22 FY23E 2QFY23E
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q Est. (%)
Revenue from Operations 2,012 2,276 2,377 2,432 2,366 2,424 2,560 2,580 9,097 9,929 2,478 -2.2
Change YoY (%) 35.4 33.0 27.8 21.7 17.6 6.5 7.7 6.1 28.9 9.2 8.9
Employee expenses 724 809 832 853 933 901 892 883 3,218 3,700 895.2 0.6
Operating expenses 192 221 228 274 267 274 279 284 905 1,104 272.7 0.3
Other Expenses 167 189 184 183 188 189 194 199 733 769 193.1 -2.3
Total Operating Expenses 1,083 1,218 1,244 1,310 1,388 1,363 1,365 1,366 4,855 5,574 1,361 0.1
Change YoY (%) 11.4 25.2 19.6 18.3 28.2 11.9 9.7 4.2 18.6 14.8 11.7
EBITDA 929 1,057 1,133 1,122 979 1,061 1,195 1,214 4,241 4,356 1,117 -5.0
Other Income 45 44 41 43 44 74 70 74 173 262 50 48.2
Depreciation 106 119 134 157 136 147 150 150 516 583 140 5.1
Finance Cost 18 18 18 18 18 18 18 17 71 71 18 2.3
PBT 850 965 1,023 989 869 970 1,097 1,121 3,827 3,964 1,009 -3.9
Change YoY (%) 63.5 45.9 35.2 22.3 2.3 0.5 7.3 13.3 39.4 3.6 4.6
Tax Provisions 217 239 249 251 223 249 274 285 957 1,031 252 -1.5
Net Profit 633 726 773 738 646 721 823 836 2,870 2,933 757 -4.7
Change YoY (%) 58.6 48.2 37.0 22.7 2.2 -0.6 6.4 13.2 39.8 2.2 4.3
Key Operating Parameters (%)
Revenue / AUM (bps) 3.5 3.6 3.6 3.6 3.6 3.6 3.6 3.4 3.6 3.5 3.6
Opex / AUM (bps) 1.9 1.9 1.9 2.0 2.1 2.0 1.9 1.8 1.90 1.97 2.0
PBT / AUM (bps) 1.5 1.5 1.5 1.5 1.3 1.4 1.5 1.5 1.50 1.40 1.5
PAT / AUM (bps) 1.1 1.1 1.2 1.1 1.0 1.1 1.1 1.1 1.13 1.04 1.1
Cost to Operating Income Ratio 53.8 53.5 52.3 53.9 58.6 56.2 53.3 52.9 53.4 56.1 54.9
EBITDA Margin 46.2 46.5 47.7 46.1 41.4 43.8 46.7 47.1 46.6 43.9 45.1
PBT Margin 42.3 42.4 43.0 40.7 36.7 40.0 42.9 43.4 42.1 39.9 40.7
Tax Rate 25.6 24.8 24.4 25.4 25.6 25.6 25.0 25.4 25.0 26.0 25.0
PAT Margin 31.4 31.9 32.5 30.4 27.3 29.8 32.1 32.4 31.6 29.5 30.5
Opex Mix (%)
Employee expenses 66.9 66.4 66.9 65.1 67.2 66.1 65.3 64.6 66.3 66.4 65.8
Operating expenses 17.7 18.1 18.3 20.9 19.3 20.1 20.5 20.8 18.6 19.8 20.0
Other Expenses 15.4 15.5 14.8 14.0 13.5 13.8 14.2 14.6 15.1 13.8 14.2
Key Parameters
QAUM (INR b) 23,078 25,500 26,700 26,700 26,200 27,100 28,726 30,450 25,500 28,252 27,510
Share of Equity AUM (%) 36.0 39.0 40.8 41.4 43.1 45.0 39.6 40.0

7 November 2022 2
CAMS

Key takeaways from the management commentary


MF Business
 In the last 10 MF launches, CAMS has won five mandates that have an AUM of
INR451b and the competitor has won five mandates which have an AUM of
INR103b.
 Operational performance has been strong with NFO collections at INR120b over
40 schemes, SIP registration of 3.8m and SIP inflows of INR75b, (+5% QoQ).
 Non-asset based MF revenue saw flattish trend as higher call center and OPE
revenues were offset by lower transaction-based revenue.
 Yield on the MF business witnessed a small compression QoQ due to 1)
telescopic pricing depletion, 2) pricing contracts that are closed for the next
three years, and 3) declining share of debt in fixed income in favor of the lower-
yield liquid segment. This was partially offset by higher overall share of equity in
the AUM mix.
 Barring one, CAMS has entered into new agreements with all major AMCs and
does not expect revisions in the next 2-3 years. Some contracts have been rolled
over at previous rates while a few have seen marginal reduction in pricing.

New businesses
Account Aggregator
 About 35+ mandates have been signed in the business
 Capital market players (Broking, Wealth Management) getting into the system is
an encouraging sign

CAMS Repository (Insurance repository)


 KYC and e-insurance policies becoming mandatory are the key drivers for
growth in this segment.
 In 2021, CAMSRep had applied for Sandbox project with IRDA for developing an
industry platform for digital assignment of policies. CAMSRep has submitted its
completion report to IRDAI and is now working to commercialize the platform
by adding more insurers and financiers onto it
 The revenue model is based on policy conversion, AMC per policy and per
transaction charges.
 Around 300m+ life insurance policies and 200m+ general insurance policies
provide huge potential once the mandate to convert the existing policies at the
time of renewal comes into effect.
 Currently, there are four licensees in the industry and hence price competition
can be expected leading to 10-20% price correction.

Alternatives
 AIF segment clocked 32% YoY growth in 2QFY23 with more than one signings every
week. CAMS has gained significant market share in this segment.
 Fintuple technologies – platform for onboarding AIF/PMS clients has started in
the current quarter
 Management expects 20-25% growth in this segment

7 November 2022 3
CAMS

Financials
 Investments will continue to happen in the new businesses although at a lower
growth pace.
 ESOP cost was INR65m in 2QFY23 v/s INR95m in 1QFY23. For FY23/FY24,
INR279/INR140m can be expected.
 CAMS currently has INR4.5b of cash and cash equivalents before accounting for
the interim dividend declared in 2QFY23.
 Hiring will be primarily towards technology and other costs are likely to be
reasonably stable in the near term. Upsides to margins will accrue from scale up
of new businesses.
 Of the new business lines, CAMS is confident of scaling up size in Alternatives,
Insurance Repository and Account Aggregator businesses.
Exhibit 1: AUM sees a QoQ uptick of 3% (INR t) Exhibit 2: Share of equity AUM continues to improve (%)
AUM (INR t) Share of equity AUM
26 27 27 26 27 43.1 45.0
22 23 39.0 40.8 41.4
18 19 19 17 19 21 34.0 34.0 35.0 36.0
16
Q1FY20
Q2FY20
Q3FY20
Q4FY20
Q1FY21
Q2FY21
Q3FY21
Q4FY21
Q1FY22
Q2FY22
Q3FY22
Q4FY22
Q1FY23
Q2FY23

Q2FY21

Q3FY21

Q4FY21

Q1FY22

Q2FY22

Q3FY22

Q4FY22

Q1FY23

Q2FY23
Source: Company, MOFSL Source: Company, MOFSL
Exhibit 3: Strong traction in SIP transactions (m) Exhibit 4: Trend in unique investor serviced (m)

SIP Transaction Processed Unique Investor Serviced

87.5 90.1 93.6


83.5 23.6 24.2
76.6 21.6 22.9
58.6 58.6 61.5 64.6 18.4
16.2 16.2 16.6 17.0
Q2FY21

Q3FY21

Q4FY21

Q1FY22

Q2FY22

Q3FY22

Q4FY22

Q1FY23

Q2FY23

Q2FY21

Q3FY21

Q4FY21

Q1FY22

Q2FY22

Q3FY22

Q4FY22

Q1FY23

Q2FY23

Source: Company, MOFSL Source: Company, MOFSL


Exhibit 5: Share of non-MF businesses improves QoQ Exhibit 6: Trend in key parameters
MF Assets Based MF Non assets Based Non Mutual Fund Revenue (bp of AUM) EBIDTA (bp of AUM)
PAT (bp of AUM)
10.4 10.3 9.0 9.7 9.8 9.7 9.3 10.5 9.6 9.8 5.6
10.6 13.2 14.7 14.1 12.7 14.1 15.2 15.0 13.9 13.8
4.2

2.8
79.0 76.5 76.3 76.3 77.5 76.2 75.5 74.5 76.5 76.4
1.4

0.0
Q1FY21

Q2FY21

Q3FY21

Q4FY21

Q1FY22

Q2FY22

Q3FY22

Q4FY22

Q1FY23

Q2FY23

Q1FY20
Q2FY20
Q3FY20
Q4FY20
Q1FY21
Q2FY21
Q3FY21
Q4FY21
Q1FY22
Q2FY22
Q3FY22
Q4FY22
Q1FY23
Q2FY23

Source: MOFSL, Company Source: MOFSL, Company

7 November 2022 4
CAMS

Tweak estimates to factor in the 2QFY23 miss


INR b Old Est. New Est. Change (%)
FY23 FY24 FY25 FY23 FY24 FY25 FY23 FY24 FY25
Revenue from Operations 10,123 11,629 13,369 9,929 11,366 13,022 -1.9 -2.3 -2.6
Change YoY (%) 11 15 15 9 14 15 -2.1 -0.4 -0.4
Employee expenses 3,700 4,218 4,893 3,700 4,144 4,641 0.0 -1.8 -5.1
Operating expenses 1,881 2,107 2,359 1,874 2,098 2,350 -0.4 -0.4 -0.4
Total Operating Expenses 5,581 6,325 7,253 5,574 6,243 6,992 -0.1 -1.3 -3.6
EBITDA 4,542 5,304 6,117 4,356 5,123 6,030 -4.1 -3.4 -1.4
Other Income 173 219 279 262 279 339 51.8 27.5 21.5
Depreciation/Finance Cost 631 645 658 654 668 682 3.7 3.6 3.5
PBT 4,084 4,878 5,737 3,964 4,734 5,687 -2.9 -3.0 -0.9
Change YoY (%) 8 20 17 4 19 20 -4.3 -0.2 2.7
Tax Provisions 1,032 1,234 1,449 1,031 1,184 1,422 -0.2 -4.1 -1.9
Net Profit 3,051 3,643 4,288 2,933 3,551 4,265 -3.9 -2.6 -0.5
AAUM (INR b) 28,252 32,321 37,000 28,252 32,321 37,000 0.0 0.0 0.0
Yields on revenue (bps) 4 4 4 3.5 3.5 3.5 -0.1 -0.1 -0.1
RoE 44.1 45.1 45.2 42.0 43.7 44.9 -2.2 -1.4 -0.3
Dividend payout ratio 65.0 65.0 65.0 65.0 65.0 65.0 0.0 0.0 0.0

7 November 2022 5
CAMS

Financials and valuations


Income Statement INR m
Y/E March 2019 2020 2021 2022 2023E 2024E 2025E
Revenue 6,936 6,996 7,055 9,097 9,929 11,366 13,022
Change (%) 8 1 1 29 9 14 15
Employee expense 2,746 2,580 2,624 3,218 3,700 4,144 4,641
Other expenses 1,754 1,544 1,471 1,638 1,874 2,098 2,350
Operating Expenses 4,501 4,124 4,094 4,855 5,574 6,243 6,992
EBITDA 2,436 2,873 2,961 4,241 4,356 5,123 6,030
Change (%) -6 18 3 43 2.7 17.6 17.7
Dep/Interest/Provisions 609 582 513 587 654 668 682
Other Income 182 217 298 173 262 279 339
PBT 2,009 2,508 2,745 3,827 3,964 4,734 5,687
Change (%) -11 25 9 39 3.6 19.4 20.1
Tax 700 773 692 957 1,031 1,184 1,422
Tax Rate (%) 35 31 25 25 26.0 25.0 25.0
PAT 1,309 1,735 2,053 2,870 2,933 3,551 4,265
Change (%) -11 33 18 40 2.2 21.0 20.1
Dividend 1,096 594 2,488 1,895 1,907 2,308 2,772

Balance Sheet INR m


Y/E March 2019 2020 2021 2022 2023E 2024E 2025E
Equity Share Capital 488 488 488 489 489 489 489
Reserves & Surplus 4,007 5,001 4,671 5,987 7,014 8,257 9,749
Net Worth 4,494 5,489 5,159 6,476 7,503 8,746 10,238
Borrowings 0 0 0 0 0 0 0
Other Liabilities 2,869 2,542 3,260 3,094 3,400 3,763 4,167
Total Liabilities 7,363 8,030 8,419 9,571 10,903 12,509 14,406
Cash and Bank balance 435 504 1,803 1,510 1,452 2,101 3,031
Investments 2,305 3,056 2,355 3,170 4,370 5,570 6,770
Net Fixed Assets 3,200 3,090 2,840 3,141 3,158 2,711 2,250
Current Assets 1,423 1,380 1,421 1,750 1,922 2,127 2,355
Total Assets 7,363 8,030 8,419 9,571 10,903 12,509 14,406
E: MOFSL Estimates

Y/E March 2019 2020 2021 2022 2023E 2024E 2025E


AAAUM (INR B) 15,841 18,149 19,984 25,500 28,252 32,321 37,000
Change (%) 15.1 14.6 10.1 27.6 10.8 14.4 14.5
Equity 6,232 6,706 6,806 10,100 11,312 13,348 15,751
Non-Equity 9,609 11,443 13,178 15,400 16,940 18,973 21,250
E: MOFSL Estimates

7 November 2022 6
CAMS

Financials and valuations


Cash flow statement INR m
Y/E March 2019 2020 2021 2022 2023E 2024E 2025E
Profit after Tax 1,304 1,734 2,053 2,870 2,933 3,551 4,265
Adjustments 369 -126 199 729 392 389 343
Change in Working Capital 347 (237) 697 (129) 269 309 342
Cashflow from Operating activities 2,020 1,371 2,950 3,470 3,594 4,249 4,950
Other Income 182 217 298 173 262 279 339
Change in Current Investments -144 -751 701 -815 -1,200 -1,200 -1,200
Change in Fixed Asset -421 174 -63 -791 -600 -150 -150
Others -53 -128 -20 -365 -137 -150 -165
Cashflow from Investing activities -436 -489 915 -1,798 -1,674 -1,222 -1,177
Interest Expense -105 -97 -79 -71 -71 -71 -71
Dividend Expense -1,321 -716 -2,488 -1,895 -1,907 -2,308 -2,772
Cashflow from Financing activities -1,426 -813 -2,567 -1,966 -1,977 -2,379 -2,843
Net Cashflow 158 69 1,298 (293) (58) 649 930
Opening Cashflow 277 435 504 1,803 1,510 1,452 2,101
Closing Cashflow 435 504 1,803 1,510 1,452 2,101 3,031

Y/E March 2019 2020 2021 2022 2023E 2024E 2025E


Margins Analysis (%)
Cost to Income Ratio 64.9 58.9 58.0 53.4 56.1 54.9 53.7
EBITDA Margins 35.1 41.1 42.0 46.6 43.9 45.1 46.3
PBT Margin 29.0 35.8 38.9 42.1 39.9 41.7 43.7
PAT Margin 18.9 24.8 29.1 31.6 29.5 31.2 32.8
Profitability Ratios (%)
RoE 29.1 34.8 38.6 49.3 42.0 43.7 44.9
Dividend Payout Ratio 83.7 34.2 121.2 66.0 65.0 65.0 65.0
Dupont Analysis (Bps of AAAUM)
Y/E March 2019 2020 2021 2022 2023E 2024E 2025E
Operating Income 4.4 3.9 3.5 3.6 3.5 3.5 3.5
Operating Expenses 2.8 2.3 2.0 1.9 2.0 1.9 1.9
EBITDA 1.5 1.6 1.5 1.7 1.5 1.6 1.6
Depreciation and Others 0.4 0.3 0.3 0.2 0.2 0.2 0.2
Other Income 0.1 0.1 0.1 0.1 0.1 0.1 0.1
PBT 1.3 1.4 1.4 1.5 1.4 1.5 1.5
Tax 0.4 0.4 0.3 0.4 0.4 0.4 0.4
ROAAAUM 0.8 1.0 1.0 1.1 1.0 1.1 1.2
Valuations 2019 2020 2021 2022 2023E 2024E 2025E
BVPS (INR) 92 112 105 132 153 179 209
Change (%) -0.4 22.1 -6.0 25.5 15.9 16.6 17.1
Price-BV (x) 26.7 21.8 23.2 18.5 16.0 13.7 11.7
EPS (INR) 26.8 35.5 42.0 58.7 60.0 72.6 87.2
Change (%) -10.5 32.5 18.4 39.8 2.2 21.0 20.1
Price-Earnings (x) 91.6 69.1 58.4 41.8 40.9 33.8 28.1
DPS (INR) 22.4 12.1 50.9 38.8 39.0 47.2 56.7
Dividend Yield (%) 0.9 0.5 2.1 1.6 1.6 1.9 2.3
E: MOFSL Estimates

7 November 2022 7
CAMS

NOTES

7 November 2022 8
CAMS

Explanation of Investment Rating


Investment Rating Expected return (over 12-month)
BUY >=15%
SELL < - 10%
NEUTRAL < - 10 % to 15%
UNDER REVIEW Rating may undergo a change
NOT RATED We have forward looking estimates for the stock but we refrain from assigning recommendation
*In case the recommendation given by the Research Analyst is inconsistent with the investment rating legend for a continuous period of 30 days, the Research Analyst shall be within following 30 days take
appropriate measures to make the recommendation consistent with the investment rating legend.
Disclosures
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
Motilal Oswal Financial Services Ltd. (MOFSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOFSL, the Research Entity (RE) as defined in the Regulations, is engaged in
the business of providing Stock broking services, Depository participant services & distribution of various financial products. MOFSL is a listed public company, the details in respect of which are available on
www.motilaloswal.com. MOFSL (erstwhile Motilal Oswal Securities Limited - MOSL) is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National
Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited (BSE), Multi Commodity Exchange of India Limited (MCX) and National Commodity & Derivatives Exchange Limited (NCDEX) for
its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) National Securities Depository Limited (NSDL),NERL, COMRIS and CCRL and is member of
Association of Mutual Funds of India (AMFI) for distribution of financial products and Insurance Regulatory & Development Authority of India (IRDA) as Corporate Agent for insurance products. Details of
associate entities of Motilal Oswal Financial Services Limited are available on the website at http://onlinereports.motilaloswal.com/Dormant/documents/List%20of%20Associate%20companies.pdf
MOFSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position in, act as principal in, and buy or sell the securities or
derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial
instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and
other related information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are
completely independent of the views of the associates of MOFSL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report.
MOFSL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that MOFSL
may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage
service transactions. Details of pending Enquiry Proceedings of Motilal Oswal Financial Services Limited are available on the website at
https://galaxy.motilaloswal.com/ResearchAnalyst/PublishViewLitigation.aspx
A graph of daily closing prices of securities is available at www.nseindia.com, www.bseindia.com. Research Analyst views on Subject Company may vary based on Fundamental research and Technical
Research. Proprietary trading desk of MOFSL or its associates maintains arm’s length distance with Research Team as all the activities are segregated from MOFSL research activity and therefore it can
have an independent view with regards to Subject Company for which Research Team have expressed their views.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary
to law, regulation or which would subject MOFSL & its group companies to registration or licensing requirements within such jurisdictions.
For Hong Kong:
This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures
Commission (SFC) pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) “SFO”. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg.
No. INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong) Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to
“Professional Investors” as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only available to professional investor and will be engaged only with
professional investors.” Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from registration. The Indian
Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong.
For U.S.
Motilal Oswal Financial Services Limited (MOFSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the
United States. In addition MOFSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and
under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOFSL, including the products and
services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act
and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any
investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption
from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission
("SEC") in order to conduct business with Institutional Investors based in the U.S., MOFSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities
International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer,
MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research
analyst account.
For Singapore
In Singapore, this report is being distributed by Motilal Oswal Capital Markets Singapore Pte Ltd (“MOCMSPL”) (Co. Reg. NO. 201129401Z) which is a holder of a capital markets services license and an
exempt financial adviser in Singapore. As per the approved agreement under Paragraph 9 of Third Schedule of Securities and Futures Act (CAP 289) and Paragraph 11 of First Schedule of Financial
Advisors Act (CAP 110) provided to MOCMSPL by Monetary Authority of Singapore. Persons in Singapore should contact MOCMSPL in respect of any matter arising from, or in connection with this
report/publication/communication. This report is distributed solely to persons who qualify as “Institutional Investors”, of which some of whom may consist of "accredited" institutional investors as defined in
section 4A(1) of the Securities and Futures Act, Chapter 289 of Singapore (“the SFA”). Accordingly, if a Singapore person is not or ceases to be such an institutional investor, such Singapore Person must
immediately discontinue any use of this Report and inform MOCMSPL.
Specific Disclosures
1 MOFSL, Research Analyst and/or his relatives does not have financial interest in the subject company, as they do not have equity holdings in the subject company.
2 MOFSL, Research Analyst and/or his relatives do not have actual/beneficial ownership of 1% or more securities in the subject company
3 MOFSL, Research Analyst and/or his relatives have not received compensation/other benefits from the subject company in the past 12 months
4 MOFSL, Research Analyst and/or his relatives do not have material conflict of interest in the subject company at the time of publication of research report
5 Research Analyst has not served as director/officer/employee in the subject company
6 MOFSL has not acted as a manager or co-manager of public offering of securities of the subject company in past 12 months
7 MOFSL has not received compensation for investment banking/ merchant banking/brokerage services from the subject company in the past 12 months
8 MOFSL has not received compensation for other than investment banking/merchant banking/brokerage services from the subject company in the past 12 months
9 MOFSL has not received any compensation or other benefits from third party in connection with the research report
10 MOFSL has not engaged in market making activity for the subject company
The associates of MOFSL may have:
- financial interest in the subject company
- actual/beneficial ownership of 1% or more securities in the subject company at the end of the month immediately preceding the date of publication of the Research Report or date of the public
appearance.
- received compensation/other benefits from the subject company in the past 12 months
- any other potential conflict of interests with respect to any recommendation and other related information and opinions.; however, the same shall have no bearing whatsoever on the specific
recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of MOFSL even though there might exist an
inherent conflict of interest in some of the stocks mentioned in the research report.
- acted as a manager or co-manager of public offering of securities of the subject company in past 12 months
- be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or
act as an advisor or lender/borrower to such company(ies)
- received compensation from the subject company in the past 12 months for investment banking / merchant banking / brokerage services or from other than said services.
- Served subject company as its clients during twelve months preceding the date of distribution of the research report.
The associates of MOFSL has not received any compensation or other benefits from third party in connection with the research report

7 November 2022 9
CAMS

Above disclosures include beneficial holdings lying in demat account of MOFSL which are opened for proprietary investments only. While calculating beneficial holdings, It does not consider demat accounts
which are opened in name of MOFSL for other purposes (i.e holding client securities, collaterals, error trades etc.). MOFSL also earns DP income from clients which are not considered in above disclosures.
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is,
or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report.
Terms & Conditions:
This report has been prepared by MOFSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any
way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOFSL. The report is based on the facts, figures
and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources
believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All
such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or
subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOFSL will not
treat recipients as customers by virtue of their receiving this report.
Disclaimer:
The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to
any other person or to the media or reproduced in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an
offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation
that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make
their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment
by any recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in
this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not
be suitable for all investors. Certain transactions -including those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not
suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this document. The Disclosures
of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. This information is subject
to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval. MOFSL, its
associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document.
They may perform or seek to perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as
a separate, distinct and independent of each other. The recipient should take this into account before interpreting the document. This report has been prepared on the basis of information that is already
available in publicly accessible media or developed through analysis of MOFSL. The views expressed are those of the analyst, and the Company may or may not subscribe to all the views expressed
therein. This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, copied, in whole or
in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction,
where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOFSL to any registration or licensing requirement within such jurisdiction. The securities
described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to
observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost
revenue or lost profits that may arise from or in connection with the use of the information. The person accessing this information specifically agrees to exempt MOFSL or any of its affiliates or employees
from, any and all responsibility/liability arising from such misuse and agrees not to hold MOFSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOFSL or any
of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays.
Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence
Address: Palm Spring Centre, 2nd Floor, Palm Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 71881000. Details of Compliance Officer: Neeraj Agarwal, Email Id:
[email protected], Contact No.:022-71881085.
Registration details of group entities.: Motilal Oswal Financial Services Ltd. (MOFSL): INZ000158836 (BSE/NSE/MCX/NCDEX); CDSL: IN-DP-16-2015; NSDL: IN-DP-NSDL-152-2000; Research Analyst:
INH000000412. AMFI: ARN.: 146822. IRDA Corporate Agent – CA0579. Motilal Oswal Financial Services Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Insurance, Bond, NCDs and IPO
products. Customer having any query/feedback/ clarification may write to [email protected]. In case of grievances for any of the services rendered by Motilal Oswal Financial Services Limited
(MOFSL) write to [email protected], for DP to [email protected].

7 November 2022 10

You might also like